Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance
Get Alerts MRK Hot Sheet
Price: $131.95 +0.15%
EPS Growth %: +47.1%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +47.1%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $1.16, $0.01 better than the analyst estimate of $1.15. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.98 billion.
GUIDANCE:
Merck sees FY2020 EPS of $5.62-$5.77, versus the consensus of $5.61. Merck sees FY2020 revenue of $48.8-50.3 billion, versus the consensus of $49.53 billion.
- At mid-January 2020 exchange rates, Merck anticipates full-year 2020 revenue to be between $48.8 billion and $50.3 billion, including a negative impact from foreign exchange of less than 1%.
- Merck expects full-year 2020 GAAP EPS to be between $4.57 and $4.72. Merck expects full-year 2020 non-GAAP EPS to be between $5.62 and $5.77, including an approximately 1.5% negative impact from foreign exchange. The non-GAAP range excludes acquisition- and divestiture-related costs and costs related to restructuring programs.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
- Carnival Corp. (CCL) Tops Q1 EPS by 3c
- RH (RH) Misses Q4 EPS by 97c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!